Literature DB >> 1720036

Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the proto-oncogene c-kit product.

A Kuriu1, H Ikeda, Y Kanakura, J D Griffin, B Druker, H Yagura, H Kitayama, J Ishikawa, T Nishiura, Y Kanayama.   

Abstract

We investigated the expression, degree of phosphorylation, and activation of the proto-oncogene c-kit product before and after stimulation with the c-kit ligand in a human factor-dependent myeloid leukemia cell line, MO7E. The culture supernatant of the BALB/3T3 fibroblast cell line, which contains the ligand for the murine c-kit product, was found to stimulate proliferation of the MO7E cell line in a dose-dependent manner. The proliferation was significantly inhibited by a tyrosine kinase inhibitor, genistein. An immunoblot technique with a monoclonal antibody specific for phosphotyrosine, showed that there was rapid, dose-dependent tyrosine-phosphorylation of the c-kit product in response to murine c-kit ligand. Furthermore, the murine c-kit ligand increased autokinase activity of the c-kit product in vitro. Similar results were obtained with human stem cell factor (SCF), a recombinant human ligand for the c-kit product. These results suggest that the phosphorylation and activation of the c-kit product are involved in proliferative signals of some human leukemia cells, as well as of normal hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720036

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Profiling the global tyrosine phosphorylation state by Src homology 2 domain binding.

Authors:  P Nollau; B J Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Authors:  M Kozlowski; L Larose; F Lee; D M Le; R Rottapel; K A Siminovitch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

3.  A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.

Authors:  Maria B Lebron; Laura Brennan; Christopher B Damoci; Marie C Prewett; Marguerita O'Mahony; Inga J Duignan; Kelly M Credille; James T DeLigio; Marina Starodubtseva; Michael Amatulli; Yiwei Zhang; Kaben D Schwartz; Douglas Burtrum; Paul Balderes; Kris Persaud; David Surguladze; Nick Loizos; Keren Paz; Helen Kotanides
Journal:  Cancer Biol Ther       Date:  2014-06-12       Impact factor: 4.742

Review 4.  Soy Isoflavones and Breast Cancer Risk: A Meta-analysis.

Authors:  Ioannis Boutas; Adamantia Kontogeorgi; Constantine Dimitrakakis; Sophia N Kalantaridou
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

5.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

Authors:  T Furitsu; T Tsujimura; T Tono; H Ikeda; H Kitayama; U Koshimizu; H Sugahara; J H Butterfield; L K Ashman; Y Kanayama
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.

Authors:  K Hashimoto; T Tsujimura; Y Moriyama; A Yamatodani; M Kimura; K Tohya; M Morimoto; H Kitayama; Y Kanakura; Y Kitamura
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study.

Authors:  Moshe Shike; Ashley S Doane; Lianne Russo; Rafael Cabal; Jorge S Reis-Filho; William Gerald; Hiram Cody; Raya Khanin; Jacqueline Bromberg; Larry Norton
Journal:  J Natl Cancer Inst       Date:  2014-09-04       Impact factor: 13.506

8.  RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells.

Authors:  Sandrine Puverel; Erkan Kiris; Satyendra Singh; Kimberly D Klarmann; Vincenzo Coppola; Jonathan R Keller; Lino Tessarollo
Journal:  Oncotarget       Date:  2016-12-20

9.  Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5.

Authors:  H Sugahara; Y Kanakura; T Furitsu; K Ishihara; K Oritani; H Ikeda; H Kitayama; J Ishikawa; K Hashimoto; Y Kanayama
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

Review 10.  Phytoestrogens: epidemiology and a possible role in cancer protection.

Authors:  H Adlercreutz
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.